Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.

All Resources
App Note
Characterizing Adoptive Cell Therapies using Bruker Cellular Analysis' Proteomic Barcode Technology

Discover how our proteomic barcode technology measures single-cell cytokine secretions to provide unique functional insights into cancer immunotherapy.

What's Inside

In this App Note we discuss:

The importance of polyfunctional cells in adoptive cell therapy.
Tracking cellular functionality to optimize manufacturing.
The Bruker Cellular Analysis IsoCode® Single-Cell Secretome platform and Workflow.
Discovering predictive clinical biomarkers that correlate with clinical outcomes.
Pre-clinical product characterization for early insights into efficacy and function.
A Deeper Look

More about this App Note

Bruker Cellular Analysis as a Critical Guide Throughout the ACT Development Workflow

Successfully developing an ACT necessitates extensive knowledge of cellular behavior that can only be obtained from single-cell functional proteomics. Download this App Note to learn more!

Row rect Shape Decorative svg added to top
Get the App Note
Back to the Top